Korea UCB Co., Ltd.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subjects With Newly or Recently Diagnosed Partial Epilepsy (NCT01498822) | Korea UCB Co., Ltd. | 2011-06-01 |
Track Korea UCB Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.